Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2017, Article ID 3676295, 7 pages
https://doi.org/10.1155/2017/3676295
Research Article

Mechanistic Model for Cancer Growth and Response to Chemotherapy

Department of Mathematics, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia

Correspondence should be addressed to Eman Simbawa; as.ude.uak@awabmise

Received 9 May 2017; Accepted 19 July 2017; Published 27 August 2017

Academic Editor: Jan Rychtar

Copyright © 2017 Eman Simbawa. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, I. Soerjomataram, and M. Ervik, GLOBOCAN, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11, International Agency for Research on Cancer, Lyon, France, 2013.
  2. R. P. Araujo and D. L. McElwain, “A history of the study of solid tumour growth: the contribution of mathematical modelling,” Bulletin of Mathematical Biology, vol. 66, no. 5, pp. 1039–1091, 2004. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  3. N. Bellomo, N. K. Li, and P. K. Maini, “On the foundations of cancer modelling: selected topics, speculations, and perspectives,” Mathematical Models and Methods in Applied Sciences, vol. 18, no. 4, pp. 593–646, 2008. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  4. H. Enderling and M. A. J. Chaplain, “Mathematical modeling of tumor growth and treatment,” Current Pharmaceutical Design, vol. 20, no. 30, pp. 4934–4940, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. E. S. Norris, J. R. King, and H. M. Byrne, “Modelling the response of spatially structured tumours to chemotherapy: Drug kinetics,” Mathematical and Computer Modelling, vol. 43, no. 7-8, pp. 820–837, 2006. View at Publisher · View at Google Scholar · View at MathSciNet
  6. J. Pascal, E. L. Bearer, Z. Wang, E. J. Koay, S. A. Curley, and V. Cristini, “Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 35, pp. 14266–14271, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Murphy, H. Jaafari, and H. M. Dobrovolny, “Differences in predictions of ODE models of tumor growth: a cautionary example,” BMC Cancer, vol. 16, no. 1, article no. 163, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. T. L. Jackson and H. M. Byrne, “A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy,” Mathematical Biosciences, vol. 164, no. 1, pp. 17–38, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Billy and J. Clairambault, “Designing proliferating cell population models with functional targets for control by anti-cancer drugs,” Discrete and Continuous Dynamical Systems. Series B, vol. 18, no. 4, pp. 865–889, 2013. View at Publisher · View at Google Scholar · View at MathSciNet
  10. J. R. Usher, “Some mathematical models for cancer chemotherapy,” Computers & Mathematics with Applications, vol. 28, no. 9, pp. 73–80, 1994. View at Google Scholar
  11. V. P. Collins, R. K. Loeffler, and H. Tivey, “Observations on growth rates of human tumors,” The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine, vol. 76, no. 5, pp. 988–1000, 1956. View at Google Scholar
  12. P. F. Verhulst, “Notice sur la loi que la population suit dans son accroissement. correspondance mathématique et physique publiée par a,” Quetelet, vol. 10, pp. 113–121, 1838. View at Google Scholar
  13. B. Gompertz, “On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies,” Philosophical Transactions of the Royal Society of London, vol. 115, pp. 513–583, 1825. View at Publisher · View at Google Scholar
  14. C. P. Winsor, “The Gompertz curve as a growth curve,” Proceedings of the National Academy of Sciences of the United States of America, vol. 18, no. 1, pp. 1–8, 1932. View at Publisher · View at Google Scholar
  15. G. I. Shapiro and J. W. Harper, “Anticancer drug targets: cell cycle and checkpoint control,” Journal of Clinical Investigation, vol. 104, no. 12, pp. 1645–1653, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Fabbrocini, N. Cameli, M. C. Romano et al., “Chemotherapy and skin reactions,” Journal of Experimental and Clinical Cancer Research, vol. 31, no. 1, article 50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Karin, C. Jobin, and F. Balkwill, “Chemotherapy, immunity and microbiota--a new triumvirate?” Nature medicine, vol. 20, no. 2, pp. 126-127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Wang, V. Probin, and D. Zhou, “Cancer therapy-induced residual bone marrow injury: mechanisms of induction and implication for therapy,” Current Cancer Therapy Reviews, vol. 2, no. 3, pp. 271–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. J. Lokich, J. D. Ahlgren, J. J. Gullo, J. A. Philips, and J. G. Fryer, “A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study,” Journal of Clinical Oncology, vol. 7, no. 4, pp. 425–432, 1989. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Alexis, E. M. Pridgen, R. Langer, and O. C. Farokhzad, “Nanoparticle technologies for cancer therapy,” Handbook of Experimental Pharmacology, vol. 197, pp. 55–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Pascal, C. E. Ashley, Z. Wang et al., “Mechanistic modeling identifies drug-uptake history as predictor of tumor drug resistance and nano-carrier-mediated response,” ACS Nano, vol. 7, no. 12, pp. 11174–11182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. I. F. Tannock, “Tumor physiology and drug resistance,” Cancer and Metastasis Reviews, vol. 20, no. 1-2, pp. 123–132, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Wang, R. Kerketta, Y.-L. Chuang et al., “Theory and experimental validation of a spatio-temporal model of chemotherapy transport to enhance tumor cell kill,” PLoS Computational Biology, vol. 12, no. 6, Article ID e1004969, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Burden and J. Faires, Numerical Analysis, Brooks/Cole, Boston, Mass, USA, 9th edition, 2011.
  25. D. M. Causon and C. G. Mingham, Introductory finite difference methods for PDEs, Bookboon, 2010.
  26. R. T. Prehn, “The Inhibition of Tumor Growth by Tumor Mass,” Cancer Research, vol. 51, no. 1, pp. 2–4, 1991. View at Google Scholar · View at Scopus
  27. R. K. Sachs, L. R. Hlatky, and P. Hahnfeldt, “Simple ODE models of tumor growth and anti-angiogenic or radiation treatment,” Mathematical and Computer Modelling, vol. 33, no. 12-13, pp. 1297–1305, 2001. View at Publisher · View at Google Scholar · View at MathSciNet